

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.00409629 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.95717608 |
| 3 | negative regulation of cell killing (GO:0031342) | 7.95717608 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.80192767 |
| 5 | negative thymic T cell selection (GO:0045060) | 7.77824620 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.43820077 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.43820077 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.88699936 |
| 9 | positive thymic T cell selection (GO:0045059) | 6.66811026 |
| 10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.54874882 |
| 11 | thymic T cell selection (GO:0045061) | 6.35269081 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 6.26348903 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.18449934 |
| 14 | positive T cell selection (GO:0043368) | 6.14155538 |
| 15 | response to interleukin-15 (GO:0070672) | 6.06380204 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.98214850 |
| 17 | T cell migration (GO:0072678) | 5.91698900 |
| 18 | interferon-gamma production (GO:0032609) | 5.89928547 |
| 19 | T cell selection (GO:0045058) | 5.79454282 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.74936803 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 5.58640778 |
| 22 | regulation of T cell tolerance induction (GO:0002664) | 5.41992484 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.17199250 |
| 24 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.11525365 |
| 25 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.11525365 |
| 26 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.05928085 |
| 27 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.05928085 |
| 28 | leukocyte aggregation (GO:0070486) | 5.03487073 |
| 29 | T cell costimulation (GO:0031295) | 4.97078513 |
| 30 | lymphocyte costimulation (GO:0031294) | 4.90140786 |
| 31 | T cell receptor signaling pathway (GO:0050852) | 4.89399900 |
| 32 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.68615471 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.67580192 |
| 34 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.53267518 |
| 35 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.44377312 |
| 36 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.43995886 |
| 37 | positive regulation of tolerance induction (GO:0002645) | 4.41997798 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 4.29727891 |
| 39 | positive regulation of isotype switching (GO:0045830) | 4.20562867 |
| 40 | mast cell activation (GO:0045576) | 4.19002712 |
| 41 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.15760406 |
| 42 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.15072204 |
| 43 | activated T cell proliferation (GO:0050798) | 4.12329058 |
| 44 | cytidine metabolic process (GO:0046087) | 4.11562390 |
| 45 | cytidine catabolic process (GO:0006216) | 4.11562390 |
| 46 | cytidine deamination (GO:0009972) | 4.11562390 |
| 47 | tolerance induction (GO:0002507) | 4.10952876 |
| 48 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.04491122 |
| 49 | regulation of response to tumor cell (GO:0002834) | 4.01898195 |
| 50 | positive regulation of response to tumor cell (GO:0002836) | 4.01898195 |
| 51 | positive regulation of immune response to tumor cell (GO:0002839) | 4.01898195 |
| 52 | regulation of immune response to tumor cell (GO:0002837) | 4.01898195 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.99896598 |
| 54 | regulation of activation of Janus kinase activity (GO:0010533) | 3.97690165 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.97564961 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.97116930 |
| 57 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.94656409 |
| 58 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.90130607 |
| 59 | regulation of cell killing (GO:0031341) | 3.89268923 |
| 60 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.87431455 |
| 61 | positive regulation of B cell mediated immunity (GO:0002714) | 3.87431455 |
| 62 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.83018882 |
| 63 | regulation of isotype switching (GO:0045191) | 3.80768327 |
| 64 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.79496946 |
| 65 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.77095970 |
| 66 | positive regulation of immunoglobulin production (GO:0002639) | 3.76990898 |
| 67 | positive regulation of cell killing (GO:0031343) | 3.76458016 |
| 68 | regulation of B cell differentiation (GO:0045577) | 3.73559523 |
| 69 | positive regulation of DNA recombination (GO:0045911) | 3.71370716 |
| 70 | positive regulation of interleukin-2 production (GO:0032743) | 3.66192202 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.66174966 |
| 72 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.65751155 |
| 73 | immunoglobulin mediated immune response (GO:0016064) | 3.64632958 |
| 74 | regulation of response to interferon-gamma (GO:0060330) | 3.64354813 |
| 75 | regulation of B cell mediated immunity (GO:0002712) | 3.60636803 |
| 76 | positive regulation of humoral immune response (GO:0002922) | 3.59452681 |
| 77 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.56914147 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 3.56705796 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.56297188 |
| 80 | cellular response to type I interferon (GO:0071357) | 3.56297188 |
| 81 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.50795248 |
| 82 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.50379923 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.49714772 |
| 84 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45457365 |
| 85 | DNA deamination (GO:0045006) | 3.45015174 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44365360 |
| 87 | T cell differentiation (GO:0030217) | 3.44129554 |
| 88 | sequestering of actin monomers (GO:0042989) | 3.43560984 |
| 89 | lymphocyte migration (GO:0072676) | 3.41528576 |
| 90 | regulation of immunoglobulin production (GO:0002637) | 3.40235154 |
| 91 | dendritic cell chemotaxis (GO:0002407) | 3.38391867 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.38190596 |
| 93 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.36691388 |
| 94 | negative regulation of phagocytosis (GO:0050765) | 3.36498915 |
| 95 | leukocyte cell-cell adhesion (GO:0007159) | 3.36257080 |
| 96 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.36227385 |
| 97 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32343271 |
| 98 | cellular defense response (GO:0006968) | 3.28289468 |
| 99 | natural killer cell activation (GO:0030101) | 3.26238085 |
| 100 | T cell activation (GO:0042110) | 3.24964289 |
| 101 | T cell homeostasis (GO:0043029) | 3.23789677 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.23348489 |
| 103 | response to interferon-beta (GO:0035456) | 3.22930534 |
| 104 | neutrophil activation involved in immune response (GO:0002283) | 3.21221925 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21057109 |
| 106 | positive regulation of granulocyte differentiation (GO:0030854) | 3.18456217 |
| 107 | neutrophil activation (GO:0042119) | 3.17193150 |
| 108 | heterotypic cell-cell adhesion (GO:0034113) | 3.16985919 |
| 109 | mast cell degranulation (GO:0043303) | 3.16788521 |
| 110 | mast cell activation involved in immune response (GO:0002279) | 3.16788521 |
| 111 | leukocyte degranulation (GO:0043299) | 3.16270736 |
| 112 | negative regulation of T cell apoptotic process (GO:0070233) | 3.15829241 |
| 113 | negative regulation of B cell proliferation (GO:0030889) | 3.10538149 |
| 114 | detection of bacterium (GO:0016045) | 3.10023824 |
| 115 | negative regulation of viral genome replication (GO:0045071) | 3.09960236 |
| 116 | alpha-beta T cell activation (GO:0046631) | 3.09631523 |
| 117 | detection of other organism (GO:0098543) | 3.08751915 |
| 118 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.08711722 |
| 119 | granulocyte activation (GO:0036230) | 3.07903417 |
| 120 | positive regulation of T cell mediated immunity (GO:0002711) | 3.06758974 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 3.06003183 |
| 122 | regulation of T cell mediated immunity (GO:0002709) | 3.05716276 |
| 123 | dendritic cell migration (GO:0036336) | 3.04657518 |
| 124 | B cell mediated immunity (GO:0019724) | 3.03791013 |
| 125 | lymphocyte chemotaxis (GO:0048247) | 3.03457497 |
| 126 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.02973578 |
| 127 | alpha-beta T cell differentiation (GO:0046632) | 3.01482410 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00191597 |
| 129 | T cell proliferation (GO:0042098) | 2.99525872 |
| 130 | positive regulation of T cell activation (GO:0050870) | 2.97299212 |
| 131 | regulation of defense response to virus by virus (GO:0050690) | 2.97129693 |
| 132 | ribosomal small subunit assembly (GO:0000028) | 2.94120634 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90726561 |
| 134 | response to type I interferon (GO:0034340) | 2.89772457 |
| 135 | lymphocyte homeostasis (GO:0002260) | 2.89160957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.73842519 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.94068112 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59498775 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.43430248 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.02518214 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.75066349 |
| 7 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.64094037 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.63390527 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.60121827 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.36677303 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.36567670 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.28461955 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.20289045 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.19519659 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.93434209 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86647554 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.74695379 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.59008115 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45115132 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34529709 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12838734 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.09466090 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.08094003 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07669567 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.07584352 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00940701 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00079550 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97210193 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95372245 |
| 30 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91188820 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84495486 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79881791 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76035398 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75391857 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69051347 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68616775 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67171654 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66960647 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61895030 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61733734 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61299719 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60414798 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59860893 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51987318 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48466524 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47338781 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47299514 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42144473 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41639479 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.40623453 |
| 51 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40370031 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38701842 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36648704 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.35141709 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34649167 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32873505 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32364676 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.31520898 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29639758 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28908710 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26218898 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25940100 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24148288 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20385803 |
| 65 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.19733752 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15724016 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13304062 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13241470 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12564303 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11872538 |
| 71 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07635606 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06397564 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05817018 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05569580 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05085043 |
| 76 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02746934 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01320245 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99960373 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99326935 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98241102 |
| 81 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97549885 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96206088 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95523214 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95038026 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93066607 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92565493 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91977497 |
| 88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91000823 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90614901 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89620857 |
| 91 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.86550331 |
| 92 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86525364 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86212956 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84115528 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83741781 |
| 96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.83619362 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83354474 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82521843 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82477516 |
| 100 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.80943556 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80880882 |
| 102 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80826490 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80578037 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.80453237 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80214587 |
| 106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79129033 |
| 107 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.78697945 |
| 108 | * P300_27268052_Chip-Seq_Bcells_Human | 0.78652980 |
| 109 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78202811 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77495412 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77018452 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76987272 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76375773 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76339643 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76315272 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74538072 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74074535 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74051178 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.73428175 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73137531 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72822608 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72486014 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72235255 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71905690 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71427545 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.70924015 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66218533 |
| 128 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65810086 |
| 129 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.64526739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.43930982 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.27021196 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.95260487 |
| 4 | MP0001800_abnormal_humoral_immune | 3.66373495 |
| 5 | MP0000685_abnormal_immune_system | 3.53671531 |
| 6 | MP0001790_abnormal_immune_system | 3.30152799 |
| 7 | MP0005387_immune_system_phenotype | 3.30152799 |
| 8 | MP0002420_abnormal_adaptive_immunity | 3.18598653 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.13190551 |
| 10 | MP0001819_abnormal_immune_cell | 3.12635245 |
| 11 | MP0002166_altered_tumor_susceptibility | 3.05568047 |
| 12 | MP0009785_altered_susceptibility_to | 3.04599666 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 3.04082806 |
| 14 | MP0002723_abnormal_immune_serum | 3.02217257 |
| 15 | MP0002398_abnormal_bone_marrow | 2.99868442 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.91765088 |
| 17 | MP0006082_CNS_inflammation | 2.75320815 |
| 18 | MP0005025_abnormal_response_to | 2.66752122 |
| 19 | MP0000716_abnormal_immune_system | 2.66146669 |
| 20 | MP0002006_tumorigenesis | 2.50936967 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.50136315 |
| 22 | MP0001873_stomach_inflammation | 2.45477922 |
| 23 | MP0002405_respiratory_system_inflammati | 2.41938412 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.41828095 |
| 25 | MP0002722_abnormal_immune_system | 2.40690509 |
| 26 | MP0002429_abnormal_blood_cell | 2.18175846 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.13210353 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.08187783 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.07264354 |
| 30 | MP0003724_increased_susceptibility_to | 2.05220540 |
| 31 | MP0003436_decreased_susceptibility_to | 2.02691989 |
| 32 | MP0004947_skin_inflammation | 2.01735391 |
| 33 | MP0003866_abnormal_defecation | 2.00545984 |
| 34 | MP0002933_joint_inflammation | 2.00042024 |
| 35 | MP0002419_abnormal_innate_immunity | 1.95263580 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.87020990 |
| 37 | MP0000858_altered_metastatic_potential | 1.81782988 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.78076320 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.69501265 |
| 40 | MP0003448_altered_tumor_morphology | 1.54947625 |
| 41 | MP0003303_peritoneal_inflammation | 1.41217124 |
| 42 | MP0001853_heart_inflammation | 1.36142650 |
| 43 | MP0002009_preneoplasia | 1.32201063 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.30603744 |
| 45 | MP0003045_fibrosis | 1.28561765 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.23261108 |
| 47 | MP0004381_abnormal_hair_follicle | 1.21764730 |
| 48 | MP0005075_abnormal_melanosome_morpholog | 1.21677787 |
| 49 | MP0004510_myositis | 1.19291127 |
| 50 | MP0008469_abnormal_protein_level | 1.19044013 |
| 51 | MP0003828_pulmonary_edema | 1.18293979 |
| 52 | MP0000490_abnormal_crypts_of | 1.15956980 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.12873092 |
| 54 | MP0005310_abnormal_salivary_gland | 1.10437154 |
| 55 | MP0004883_abnormal_blood_vessel | 1.07532454 |
| 56 | MP0003646_muscle_fatigue | 1.05995002 |
| 57 | MP0004130_abnormal_muscle_cell | 1.00468382 |
| 58 | MP0002132_abnormal_respiratory_system | 0.99801994 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 0.98271296 |
| 60 | MP0008057_abnormal_DNA_replication | 0.93098333 |
| 61 | MP0001533_abnormal_skeleton_physiology | 0.92978802 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.87749288 |
| 63 | MP0003077_abnormal_cell_cycle | 0.84011897 |
| 64 | MP0001851_eye_inflammation | 0.83503950 |
| 65 | MP0003690_abnormal_glial_cell | 0.81930710 |
| 66 | MP0006054_spinal_hemorrhage | 0.81440579 |
| 67 | MP0003693_abnormal_embryo_hatching | 0.81163494 |
| 68 | MP0009763_increased_sensitivity_to | 0.80875500 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.80486830 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 0.80486830 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 0.77687769 |
| 72 | MP0010094_abnormal_chromosome_stability | 0.76466964 |
| 73 | MP0000604_amyloidosis | 0.73353891 |
| 74 | MP0003075_altered_response_to | 0.73262302 |
| 75 | MP0004957_abnormal_blastocyst_morpholog | 0.72328498 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.68498764 |
| 77 | MP0005164_abnormal_response_to | 0.67276760 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.66418474 |
| 79 | MP0005023_abnormal_wound_healing | 0.66355869 |
| 80 | MP0010352_gastrointestinal_tract_polyps | 0.65632869 |
| 81 | MP0000343_altered_response_to | 0.65244207 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.64690098 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.63973752 |
| 84 | MP0005166_decreased_susceptibility_to | 0.62446431 |
| 85 | MP0002163_abnormal_gland_morphology | 0.59707439 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.58169633 |
| 87 | MP0000477_abnormal_intestine_morphology | 0.57863476 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.57712427 |
| 89 | MP0001919_abnormal_reproductive_system | 0.57416037 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.57260245 |
| 91 | MP0008260_abnormal_autophagy | 0.56383744 |
| 92 | MP0009764_decreased_sensitivity_to | 0.55880472 |
| 93 | MP0005390_skeleton_phenotype | 0.54834237 |
| 94 | MP0001765_abnormal_ion_homeostasis | 0.54243123 |
| 95 | MP0000609_abnormal_liver_physiology | 0.51869005 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.51385878 |
| 97 | MP0008058_abnormal_DNA_repair | 0.51292465 |
| 98 | MP0008874_decreased_physiological_sensi | 0.51264400 |
| 99 | MP0008873_increased_physiological_sensi | 0.51238057 |
| 100 | MP0003795_abnormal_bone_structure | 0.49399281 |
| 101 | MP0001191_abnormal_skin_condition | 0.49371621 |
| 102 | MP0003252_abnormal_bile_duct | 0.49145688 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.48704784 |
| 104 | MP0001663_abnormal_digestive_system | 0.46823520 |
| 105 | MP0002822_catalepsy | 0.46748238 |
| 106 | MP0000249_abnormal_blood_vessel | 0.45653158 |
| 107 | MP0000920_abnormal_myelination | 0.45184784 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.44714482 |
| 109 | MP0002095_abnormal_skin_pigmentation | 0.44697927 |
| 110 | MP0001243_abnormal_dermal_layer | 0.44083027 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.42575559 |
| 112 | MP0000313_abnormal_cell_death | 0.41927495 |
| 113 | MP0002083_premature_death | 0.40854619 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.40363419 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.40225838 |
| 116 | MP0008872_abnormal_physiological_respon | 0.38670101 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.37554501 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.37224344 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.37007563 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.36632945 |
| 121 | MP0009278_abnormal_bone_marrow | 0.36629146 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.35673469 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.35090133 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34781905 |
| 125 | MP0003787_abnormal_imprinting | 0.34164094 |
| 126 | MP0000367_abnormal_coat/_hair | 0.33961683 |
| 127 | MP0000598_abnormal_liver_morphology | 0.33395994 |
| 128 | MP0000350_abnormal_cell_proliferation | 0.33321005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.28524833 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.05768499 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.09715634 |
| 4 | Abnormality of T cells (HP:0002843) | 5.34477282 |
| 5 | Chronic otitis media (HP:0000389) | 5.32334111 |
| 6 | IgM deficiency (HP:0002850) | 5.14336358 |
| 7 | Nasal polyposis (HP:0100582) | 5.09811096 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.03943487 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 5.00178997 |
| 10 | Combined immunodeficiency (HP:0005387) | 4.99457169 |
| 11 | Myositis (HP:0100614) | 4.95369755 |
| 12 | IgG deficiency (HP:0004315) | 4.32337093 |
| 13 | Recurrent viral infections (HP:0004429) | 4.26252394 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 4.21153317 |
| 15 | Lymphopenia (HP:0001888) | 4.15084256 |
| 16 | Agammaglobulinemia (HP:0004432) | 4.00886219 |
| 17 | Recurrent sinusitis (HP:0011108) | 4.00619794 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 4.00483570 |
| 19 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.00124744 |
| 20 | Meningitis (HP:0001287) | 3.99812820 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.98322886 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.82833580 |
| 23 | Encephalitis (HP:0002383) | 3.65113435 |
| 24 | Thyroiditis (HP:0100646) | 3.62956279 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.61764680 |
| 26 | Abnormality of B cell number (HP:0010975) | 3.57794355 |
| 27 | B lymphocytopenia (HP:0010976) | 3.57794355 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.57729275 |
| 29 | Optic neuritis (HP:0100653) | 3.54812403 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.54812403 |
| 31 | Pustule (HP:0200039) | 3.54002506 |
| 32 | Bronchitis (HP:0012387) | 3.52486304 |
| 33 | Vasculitis (HP:0002633) | 3.52310093 |
| 34 | Abnormality of eosinophils (HP:0001879) | 3.46587248 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 3.44249987 |
| 36 | Chronic sinusitis (HP:0011109) | 3.42769513 |
| 37 | Stomatitis (HP:0010280) | 3.41307359 |
| 38 | Eczematoid dermatitis (HP:0000976) | 3.40719580 |
| 39 | Joint swelling (HP:0001386) | 3.37025438 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34689747 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34689747 |
| 42 | Inflammation of the large intestine (HP:0002037) | 3.28283410 |
| 43 | Increased IgM level (HP:0003496) | 3.27500772 |
| 44 | Chronic diarrhea (HP:0002028) | 3.19253901 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.18878803 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.15373124 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 3.12285918 |
| 48 | Orchitis (HP:0100796) | 3.10943690 |
| 49 | Leukocytosis (HP:0001974) | 3.04241325 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 3.02444466 |
| 51 | Pulmonary infiltrates (HP:0002113) | 3.00026738 |
| 52 | IgA deficiency (HP:0002720) | 2.99142325 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95920895 |
| 54 | Obstructive lung disease (HP:0006536) | 2.95920895 |
| 55 | Eosinophilia (HP:0001880) | 2.95881354 |
| 56 | Keratoconjunctivitis sicca (HP:0001097) | 2.94843165 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.94185251 |
| 58 | Lymphoma (HP:0002665) | 2.93627413 |
| 59 | Recurrent otitis media (HP:0000403) | 2.88769025 |
| 60 | Hypoproteinemia (HP:0003075) | 2.87217672 |
| 61 | Hemoptysis (HP:0002105) | 2.86248551 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.83860260 |
| 63 | Thrombocytosis (HP:0001894) | 2.78846146 |
| 64 | Gastrointestinal infarctions (HP:0005244) | 2.77982602 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.77689659 |
| 66 | Verrucae (HP:0200043) | 2.75918711 |
| 67 | Papilloma (HP:0012740) | 2.75918711 |
| 68 | Stomach cancer (HP:0012126) | 2.75161935 |
| 69 | Colitis (HP:0002583) | 2.70491306 |
| 70 | Granulocytopenia (HP:0001913) | 2.68895303 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.68820300 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.66602367 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.64263809 |
| 74 | Recurrent skin infections (HP:0001581) | 2.61469463 |
| 75 | Emphysema (HP:0002097) | 2.60479164 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.57547324 |
| 77 | Hemiplegia (HP:0002301) | 2.54507564 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.54147293 |
| 79 | Arterial thrombosis (HP:0004420) | 2.54007396 |
| 80 | Hypochromic anemia (HP:0001931) | 2.52555548 |
| 81 | Urticaria (HP:0001025) | 2.51377225 |
| 82 | Pulmonary embolism (HP:0002204) | 2.45485983 |
| 83 | Gingivitis (HP:0000230) | 2.44756440 |
| 84 | Basal cell carcinoma (HP:0002671) | 2.43971456 |
| 85 | Increased IgE level (HP:0003212) | 2.37440279 |
| 86 | Chest pain (HP:0100749) | 2.26782044 |
| 87 | Anorexia (HP:0002039) | 2.25279694 |
| 88 | Cellulitis (HP:0100658) | 2.21507654 |
| 89 | Ureteral stenosis (HP:0000071) | 2.17226305 |
| 90 | Gangrene (HP:0100758) | 2.13666212 |
| 91 | Acute hepatic failure (HP:0006554) | 2.11306023 |
| 92 | Petechiae (HP:0000967) | 2.10871728 |
| 93 | Epistaxis (HP:0000421) | 2.10440706 |
| 94 | Glomerulopathy (HP:0100820) | 2.09988853 |
| 95 | Bronchiectasis (HP:0002110) | 2.08031871 |
| 96 | Restrictive lung disease (HP:0002091) | 2.07652967 |
| 97 | Skin rash (HP:0000988) | 2.02163315 |
| 98 | Aplastic anemia (HP:0001915) | 2.01722975 |
| 99 | Amaurosis fugax (HP:0100576) | 2.00946151 |
| 100 | Skin ulcer (HP:0200042) | 2.00789284 |
| 101 | Arthralgia (HP:0002829) | 1.97402885 |
| 102 | Abnormal platelet volume (HP:0011876) | 1.96589109 |
| 103 | Ureteral obstruction (HP:0006000) | 1.94751549 |
| 104 | 3-Methylglutaconic aciduria (HP:0003535) | 1.93708212 |
| 105 | Polyneuropathy (HP:0001271) | 1.91671661 |
| 106 | Periodontitis (HP:0000704) | 1.91477958 |
| 107 | Sepsis (HP:0100806) | 1.91001198 |
| 108 | Keratitis (HP:0000491) | 1.90733495 |
| 109 | Increased serum ferritin (HP:0003281) | 1.85700616 |
| 110 | Hypoplasia of the thymus (HP:0000778) | 1.85281712 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.83524313 |
| 112 | Abnormality of oral frenula (HP:0000190) | 1.82999289 |
| 113 | Abnormality of macrophages (HP:0004311) | 1.82418288 |
| 114 | Gingival bleeding (HP:0000225) | 1.81991717 |
| 115 | Microcytic anemia (HP:0001935) | 1.80679192 |
| 116 | Prostate neoplasm (HP:0100787) | 1.80231817 |
| 117 | Hepatitis (HP:0012115) | 1.79731990 |
| 118 | Pulmonary fibrosis (HP:0002206) | 1.79676038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.80840326 |
| 2 | MAP4K1 | 6.06574067 |
| 3 | ITK | 3.32883122 |
| 4 | RIPK4 | 2.93098527 |
| 5 | JAK3 | 2.90130939 |
| 6 | ZAP70 | 2.80615743 |
| 7 | STK10 | 2.67022154 |
| 8 | JAK1 | 2.64224889 |
| 9 | IKBKE | 2.58508790 |
| 10 | TYK2 | 2.48188321 |
| 11 | FGFR4 | 2.43380211 |
| 12 | GRK6 | 2.34573746 |
| 13 | MST4 | 2.33074850 |
| 14 | MAP3K14 | 2.21814563 |
| 15 | LCK | 2.06084594 |
| 16 | NLK | 1.93968968 |
| 17 | BLK | 1.91025402 |
| 18 | SYK | 1.87118990 |
| 19 | CAMKK2 | 1.83439169 |
| 20 | CSK | 1.82193707 |
| 21 | TBK1 | 1.81420414 |
| 22 | TEC | 1.74720176 |
| 23 | KIT | 1.69267548 |
| 24 | BTK | 1.68296463 |
| 25 | FGFR3 | 1.57544749 |
| 26 | IRAK4 | 1.52153332 |
| 27 | CLK1 | 1.45660332 |
| 28 | CAMKK1 | 1.40356211 |
| 29 | LRRK2 | 1.39487628 |
| 30 | NME2 | 1.37843837 |
| 31 | GRK7 | 1.35085028 |
| 32 | CSF1R | 1.34941225 |
| 33 | MAP3K13 | 1.34742673 |
| 34 | PRKCH | 1.28204655 |
| 35 | TESK2 | 1.24105560 |
| 36 | PRKCQ | 1.22550499 |
| 37 | HCK | 1.21673201 |
| 38 | IKBKB | 1.17023948 |
| 39 | MAP3K11 | 1.11774061 |
| 40 | LYN | 1.10624094 |
| 41 | FES | 1.07717323 |
| 42 | EEF2K | 1.02216281 |
| 43 | KDR | 1.00680926 |
| 44 | MARK3 | 0.98506266 |
| 45 | PIM1 | 0.95623183 |
| 46 | FGR | 0.94589383 |
| 47 | PTK2B | 0.86849302 |
| 48 | MAP3K10 | 0.86541239 |
| 49 | TNK2 | 0.78664170 |
| 50 | RPS6KA4 | 0.77230173 |
| 51 | MAP2K3 | 0.75708592 |
| 52 | LIMK1 | 0.75610768 |
| 53 | SIK2 | 0.73215752 |
| 54 | TGFBR2 | 0.69522710 |
| 55 | JAK2 | 0.68206192 |
| 56 | PIK3CG | 0.65638027 |
| 57 | MELK | 0.63707611 |
| 58 | CHUK | 0.63191319 |
| 59 | CDC42BPA | 0.62019799 |
| 60 | CDK4 | 0.61825215 |
| 61 | MAP3K12 | 0.58581569 |
| 62 | MAP2K6 | 0.56732527 |
| 63 | SIK3 | 0.56140951 |
| 64 | IRAK3 | 0.55047725 |
| 65 | MAPK11 | 0.53253888 |
| 66 | FLT3 | 0.52954887 |
| 67 | TESK1 | 0.51351790 |
| 68 | SCYL2 | 0.51325380 |
| 69 | TAOK3 | 0.51107865 |
| 70 | GRK5 | 0.49890336 |
| 71 | FYN | 0.49425984 |
| 72 | MAP3K3 | 0.49370183 |
| 73 | PKN2 | 0.47563939 |
| 74 | BMPR2 | 0.46512501 |
| 75 | PTK6 | 0.46030070 |
| 76 | MAPKAPK3 | 0.45840784 |
| 77 | EPHA3 | 0.45447345 |
| 78 | MAP3K7 | 0.45422762 |
| 79 | MAP3K1 | 0.43261494 |
| 80 | ALK | 0.42912416 |
| 81 | STK4 | 0.42889077 |
| 82 | PDK1 | 0.40827484 |
| 83 | IGF1R | 0.40661330 |
| 84 | INSR | 0.40535791 |
| 85 | PRKD2 | 0.38575091 |
| 86 | PASK | 0.38419462 |
| 87 | EPHB1 | 0.38082960 |
| 88 | ERN1 | 0.36318488 |
| 89 | MATK | 0.35840437 |
| 90 | PIK3CA | 0.35075016 |
| 91 | NUAK1 | 0.34993061 |
| 92 | HIPK2 | 0.33693972 |
| 93 | CDK8 | 0.32430898 |
| 94 | TLK1 | 0.32124309 |
| 95 | MAP2K2 | 0.31672976 |
| 96 | BCKDK | 0.31473360 |
| 97 | MAPK7 | 0.31424474 |
| 98 | ADRBK1 | 0.31093231 |
| 99 | IRAK1 | 0.30041066 |
| 100 | CDK6 | 0.29373013 |
| 101 | PRKCD | 0.28900981 |
| 102 | PDPK1 | 0.28714785 |
| 103 | CDC7 | 0.28697564 |
| 104 | MOS | 0.27978092 |
| 105 | TAOK1 | 0.26650452 |
| 106 | TSSK6 | 0.26169992 |
| 107 | STK24 | 0.25842924 |
| 108 | MAPK4 | 0.24838573 |
| 109 | NEK2 | 0.24040334 |
| 110 | ACVR1B | 0.23310955 |
| 111 | PDGFRB | 0.22155658 |
| 112 | CDK9 | 0.22147931 |
| 113 | MAPK3 | 0.21922420 |
| 114 | TGFBR1 | 0.21235530 |
| 115 | NEK9 | 0.21152898 |
| 116 | TTN | 0.21138429 |
| 117 | ADRBK2 | 0.20392431 |
| 118 | RPS6KA6 | 0.20300475 |
| 119 | ABL1 | 0.19816370 |
| 120 | MAP3K8 | 0.19308087 |
| 121 | RAF1 | 0.18744416 |
| 122 | MAPKAPK2 | 0.18237664 |
| 123 | MAPK12 | 0.18190914 |
| 124 | RPS6KA5 | 0.17895206 |
| 125 | TYRO3 | 0.16756303 |
| 126 | TRIB3 | 0.15304987 |
| 127 | CDK12 | 0.14583130 |
| 128 | PRPF4B | 0.14529206 |
| 129 | RPS6KB2 | 0.14416283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.34412734 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.20897948 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.61437655 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.52738363 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.25550775 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.08591760 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.01649019 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.97609183 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.72238477 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.41816955 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31610678 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12947767 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11468295 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89876648 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84335200 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.79206135 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66609520 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65274613 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64621271 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51543768 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47739271 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44729016 |
| 23 | DNA replication_Homo sapiens_hsa03030 | 1.38304176 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.36971761 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30216162 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28527799 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22548798 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21353956 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19806412 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19008014 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.17244555 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10748957 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.10551668 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09245016 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.05656890 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.04714571 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03155110 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 1.01256421 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 0.95665351 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91929733 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89773478 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89687596 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87553946 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.85324763 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82169915 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82136411 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80299014 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79042781 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.77120812 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.76937230 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.74745112 |
| 52 | Spliceosome_Homo sapiens_hsa03040 | 0.74328697 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.73961601 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70344197 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68083027 |
| 56 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66973106 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65783247 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.65580492 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65325012 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.64122739 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.63936474 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62955272 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60777140 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.60154712 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.59801134 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55462021 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55061939 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.49257838 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.47051412 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46534087 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45567643 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45290069 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43929855 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43794664 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41966449 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41913785 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40937489 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39923421 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39647934 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.39636073 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38651102 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.37761655 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36883960 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36242711 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35847903 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35386021 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35301679 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32792738 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31984685 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31698817 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31529291 |
| 92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.30891715 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29747324 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28876155 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28413581 |
| 96 | Cell cycle_Homo sapiens_hsa04110 | 0.27073022 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.26170606 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25783865 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25736098 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25130951 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22335965 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21705069 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21365389 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.21287335 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20671588 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.19992014 |
| 107 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.18770655 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.17210865 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16266234 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.15678341 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14655998 |
| 112 | Protein export_Homo sapiens_hsa03060 | 0.14647680 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13961583 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13889678 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.13817041 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.13483915 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13479338 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.11601239 |
| 119 | RNA transport_Homo sapiens_hsa03013 | 0.11475023 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11024985 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.10922513 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.10753251 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.10272073 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10168842 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.08185607 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.07879002 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.07506942 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.07189484 |

